V. Molecular classification and risk stratification of myeloma

od Bergsagel, P. Leif, Chesi, Marta
Wydane 2013

Many Multiple Myelomas: Making More of the Molecular Mayhem

od Chesi, Marta, Bergsagel, P. Leif
Wydane 2011

Molecular pathogenesis of multiple myeloma: basic and clinical updates

od Chesi, Marta, Bergsagel, P. Leif
Wydane 2013

Comprehensive identification of somatic mutations in chronic lymphocytic leukemia

od Bergsagel, P. Leif, Kuehl, W. Michael
Wydane 2011

Molecular pathogenesis of multiple myeloma and its premalignant precursor

od Kuehl, W. Michael, Bergsagel, P. Leif
Wydane 2012

Detailing the genomic landscape of myeloma

od Bergsagel, P. Leif, Kuehl, W. Michael
Wydane w Blood (2018)

Approach to the treatment of multiple myeloma: a clash of philosophies

od Rajkumar, S. Vincent, Gahrton, Gösta, Bergsagel, P. Leif
Wydane 2011

Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process

od Hallek, Michael, Bergsagel, P. Leif, Anderson, Kenneth C.
Wydane 1998

UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression

od Hussain, Sajjad, Bedekovics, Tibor, Chesi, Marta, Bergsagel, P. Leif, Galardy, Paul J.
Wydane w Oncotarget (2015)

Characterization of MYC Translocations in Multiple Myeloma Cell Lines

od Dib, Amel, Gabrea, Ana, Glebov, Oleg K., Bergsagel, P. Leif, Kuehl, W. Michael
Wydane 2008

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

od Bergsagel, P. Leif, Kuehl, W. Michael, Zhan, Fenghuang, Sawyer, Jeffrey, Barlogie, Bart, Shaughnessy, John
Wydane 2005

Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma

od Bergsagel, P. Leif, Mateos, María-Victoria, Gutierrez, Norma C., Rajkumar, S. Vincent, San Miguel, Jesús F.
Wydane 2013

Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma

od Bergsagel, P. Leif, Chesi, Marta, Nardini, Elena, Brents, Leslie A., Kirby, Suzanne L., Kuehl, W. Michael
Wydane 1996

Dynamic CD138 surface expression regulates switch between myeloma growth and dissemination

od Akhmetzyanova, Ilseyar, McCarron, Mark J., Parekh, Samir, Chesi, Marta, Bergsagel, P. Leif, Fooksman, David R.
Wydane w Leukemia (2019)

Classical and/or alternative NF-κB pathway activation in multiple myeloma

od Demchenko, Yulia N., Glebov, Oleg K., Zingone, Adriana, Keats, Jonathan J., Bergsagel, P. Leif, Kuehl, W. Michael
Wydane 2010

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

od Chesi, Marta, Nardini, Elena, Brents, Leslie A., Schröck, Evelin, Ried, Thomas, Kuehl, W. Michael, Bergsagel, P. Leif
Wydane 1997

Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups

od Asmann, Yan W., Parikh, Kaushal, Bergsagel, P. Leif, Dong, Haidong, Adjei, Alex A., Borad, Mitesh J., Mansfield, Aaron S.
Wydane w NPJ Precis Oncol (2021)

Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications

od Chng, Wee J., Remstein, Ellen D., Fonseca, Rafael, Bergsagel, P. Leif, Vrana, Julie A., Kurtin, Paul J., Dogan, Ahmet
Wydane 2009

Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma

od Bordini, Jessica, Bertilaccio, Maria Teresa Sabrina, Ponzoni, Maurilio, Fermo, Isabella, Chesi, Marta, Bergsagel, P. Leif, Camaschella, Clara, Campanella, Alessandro
Wydane w Haematologica (2015)

Molecular Mechanisms of Bortezomib Resistant Adenocarcinoma Cells

od Suzuki, Erika, Demo, Susan, Deu, Edgar, Keats, Jonathan, Arastu-Kapur, Shirin, Bergsagel, P. Leif, Bennett, Mark K., Kirk, Christopher J.
Wydane 2011